Korro Bio (KRRO) Interest Coverage Ratio (2018 - 2026)
Korro Bio's (KRRO) quarterly Interest Coverage Ratio came in at 0.9 in Q1 2026, up 99.28% YoY from 0.45 in Q1 2025, and up 99.82% on a QoQ basis from 503.96 in Q4 2025.
Korro Bio (KRRO) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Korro Bio (KRRO) has 9 years of Interest Coverage Ratio data on file, last reported at 0.9 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 99.28% year-over-year to 0.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.16 (up 96.76% YoY) and the FY2025 annual result came in at 0.6, up 86.03% from the prior year.
- Interest Coverage Ratio rose to 0.9 in Q1 2026, from 503.96 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.32 in Q3 2024 to a low of 6382.67 in Q3 2023.
- A 5-year average of 817.94 and a median of 26.96 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio slumped 33300.79% — and 2024, when it surged 99.99%.
- Tracing KRRO's Interest Coverage Ratio over 5 years: stood at 12.94 in 2022, then sank by 1979.02% to 268.93 in 2023, then advanced by 14.33% to 230.4 in 2024, then slumped by 118.73% to 503.96 in 2025, then soared by 99.82% to 0.9 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.9 (Q1 2026), 503.96 (Q4 2025), and 0.46 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Korro Bio | 228.60 Mn | 113.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.32 |
| Mar 31, 2026 | -0.90 |
| Dec 31, 2025 | -503.96 |
| Sep 30, 2025 | -0.46 |
| Jun 30, 2025 | -0.74 |
| Mar 31, 2025 | -125.10 |
| Dec 31, 2024 | -230.40 |
| Sep 30, 2024 | -0.32 |
| Jun 30, 2024 | -0.35 |
| Mar 31, 2024 | -107.27 |
| Dec 31, 2023 | -268.93 |
| Sep 30, 2023 | -6,382.67 |
| Jun 30, 2023 | -6,136.00 |
| Mar 31, 2023 | -70.73 |
| Dec 31, 2022 | -12.94 |
| Sep 30, 2022 | -19.11 |
| Jun 30, 2022 | -26.96 |
| Mar 31, 2022 | -18.13 |
| Dec 31, 2021 | -117.36 |
| Sep 30, 2021 | -1.90 |